Results 71 to 80 of about 1,188 (177)

Early Experience of Treprostinil Dry‐Powdered Inhaler in Patients With Pulmonary Hypertension Related to Fibrosing Interstitial Lung Disease at a Tertiary Referral Center

open access: yesPulmonary Circulation, Volume 16, Issue 1, January 2026.
ABSTRACT A dry powder inhaler (DPI) formulation of treprostinil was FDA‐approved in March 2022 for patients with pulmonary arterial hypertension or pulmonary hypertension associated with ILD (PH‐ILD). In this letter we describe our real‐world single‐center experience using Treprostinil DPI in patients with PH‐ILD patients within our first year of using
Jordin L. Rice   +7 more
wiley   +1 more source

Extracting Histologic Features to Distinguish Primary and Metastatic Squamous Cell Carcinoma of the Lung

open access: yesPathology International, Volume 76, Issue 1, January 2026.
A scoring‐based formula was developed to distinguish primary from metastatic lung squamous cell carcinoma. Six features suggestive of primary and one of metastasis were scored from 0 to 2 by seven pathologists. The formula derived from multivariate analysis showed high AUC and sensitivity in both internal (n = 85) and external (n = 20) cohorts.
Yuri Tachibana   +9 more
wiley   +1 more source

Combined pulmonary fibrosis and emphysema

open access: yes, 2013
The advent of computed tomography permitted recognition of the coexistence of pulmonary fibrosis and emphysema (CPFE). Emphysema is usually encountered in the upper lobes preceding fibrosis of the lower lobes, and patients are smokers, predominantly male,
Papiris, S.A.   +6 more
core   +1 more source

Severe pulmonary hypertension due to combined pulmonary fibrosis and emphysema: another cause of death among smokers

open access: yesAutopsy and Case Reports, 2017
In 2005, the combined pulmonary fibrosis and emphysema (CPFE) was first defined as a distinct entity, which comprised centrilobular or paraseptal emphysema in the upper pulmonary lobes, and fibrosis in the lower lobes accompanied by reduced diffused ...
André Carramenha de Góes Hirano   +6 more
doaj   +1 more source

Deterioration of Respiratory Symptoms in Uncontrolled CPFE: A Case Report

open access: yesJurnal Respirasi
Introduction: Chronic obstructive pulmonary disease (COPD) has a global impact on health and increases healthcare costs. Combined pulmonary fibrosis and emphysema (CPFE) combines interstitial lung disease (ILD) and emphysema.
Frans Raffael, Amira Permatasari Tarigan
doaj   +1 more source

Effect of Total Psoas Muscle Area and Serum Albumin on Outcomes After Lung Transplantation

open access: yesClinical Transplantation, Volume 39, Issue 9, September 2025.
ABSTRACT Background Sarcopenia of the psoas muscle and hypoalbuminemia indicate poor nutritional status, inflammation, and frailty in lung transplant (LT) candidates, correlating with worse post‐transplant outcomes. Methods Retrospective study of LT recipients (2015–2023) examining the association of total psoas muscle area (TPA) and serum albumin with
Domingo J. Franco‐Palacios   +14 more
wiley   +1 more source

Combined pulmonary fibrosis and emphysema, a clinical review

open access: yes, 2016
Combined Pulmonary Fibrosis and Emphysema (CPFE) refers to the coexistence of upper lobe predominant emphysema with diffuse pulmonary fibrosis, mainly in the lower lobes.
Bouros, D., Tzilas, V.
core   +1 more source

Combined pulmonary fibrosis and emphysema syndrome: clinical research progress

open access: yesThe Egyptian Journal of Bronchology
Combined pulmonary fibrosis and emphysema (CPFE) is a distinct radiological–clinical syndrome defined by the coexistence of upper-lobe emphysema and lower-lobe fibrosis. It predominantly affects elderly heavy smokers and exhibits a hallmark physiological
Xiulin Ye   +3 more
doaj   +1 more source

Respiratory Impedance is Associated with Ventilation and Diffusing Capacity in Patients with Idiopathic Pulmonary Fibrosis Combined with Emphysema

open access: yesInternational Journal of COPD, 2022
Yuji Yamamoto,1 Haruhiko Hirata,1 Takayuki Shiroyama,1 Tomoki Kuge,1 Kinnosuke Matsumoto,1 Midori Yoneda,1 Makoto Yamamoto,1 Yujiro Naito,1 Yasuhiko Suga,1 Kiyoharu Fukushima,1 Kotaro Miyake,1 Shohei Koyama,1 Kota Iwahori,1 Izumi Nagatomo,1 Yoshito ...
Yamamoto Y   +15 more
doaj  

Combined pulmonary fibrosis and emphysema in connective tissue disease

open access: yes, 2012
International audiencePurpose of review This review discusses combined pulmonary fibrosis and emphysema (CPFE) in the setting of connective tissue disease.
Cottin, Vincent, Cordier, Jean-François
core   +1 more source

Home - About - Disclaimer - Privacy